Modalities of use of oral propranolol in proliferative infantile haemangiomas: an international survey among practitioners

J. Robert (1) , E. Tavernier (2, 3) , O. Boccara (4, 5) , J. Mashiah (6) , J. Mazereeuw‐hautier (7) , A. Maruani (2, 1)

1 CHRU Tours - Centre Hospitalier Régional Universitaire de Tours
2 SPHERE - MethodS in Patients-centered outcomes and HEalth ResEarch
3 CIC - Centre d’Investigation Clinique [Tours] CIC 1415
4 Hôpital Necker - Enfants Malades [AP-HP]
5 Imagine - U1163 - Imagine - Institut des maladies génétiques (IHU)
6 TAU - Tel Aviv University
7 CHU Toulouse - Centre Hospitalier Universitaire de Toulouse

Domaines: Sciences du Vivant [q-bio]

J. Robert, E. Tavernier, O. Boccara, J. Mashiah, J. Mazereeuw‐hautier, et al.. Modalities of use of oral propranolol in proliferative infantile haemangiomas: an international survey among practitioners. British Journal of Dermatology, 2020, 183 (3), pp.573-575. ⟨10.1111/bjd.19047⟩. ⟨hal-03342752⟩